A Form 4 filed with the SEC on September 22, 2026, discloses that Vanessa Ames Wittman, a director of Oscar Health, Inc. (NYSE:OSCR), sold 25,000 shares of Class A Common Stock on September 18, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Vanessa Ames Wittman, listed as a Director of Oscar Health, Inc.
  • Shares sold: 25,000 shares of Class A Common Stock disposed of (transaction code S) on September 18, 2026.
  • Sale price: $32.24 per share, as stated in the filing.
  • Trading plan: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2026.
  • Remaining ownership: Following the transaction, Wittman beneficially owns 112,121 shares directly, which includes shares to be issued in connection with the vesting of one or more restricted stock units.
  • No derivative transactions: Table II reports no derivative securities activity.

Director Wittman's Share Sale and Remaining Position at Oscar Health

According to the filing, Vanessa Ames Wittman, a director at Oscar Health, Inc. (NYSE:OSCR), disposed of 25,000 shares of Class A Common Stock at a price of $32.24 per share on September 18, 2026. The filing notes that the transaction was carried out under a Rule 10b5-1 trading plan that Wittman adopted on June 18, 2026, meaning the sale was pre-scheduled in accordance with SEC guidelines governing such plans.

After the reported sale, the filing states that Wittman directly holds 112,121 shares of Class A Common Stock. The filing further notes that this total includes shares to be issued in connection with the vesting of one or more restricted stock units. Ownership is reported as direct, with no indirect beneficial ownership listed in connection with this transaction.

Table II of the filing, covering derivative securities such as options or warrants, shows no transactions. The Form 4 was signed by Melissa Curtin as attorney-in-fact on September 22, 2026, and the box indicating a Rule 10b5-1(c) plan was checked on the cover of the form.

What Was Disclosed

The filing discloses a single open-market sale of 25,000 shares of Oscar Health Class A Common Stock by director Vanessa Ames Wittman at $32.24 per share on September 18, 2026, conducted under a pre-adopted Rule 10b5-1 plan, leaving her with 112,121 shares beneficially owned directly.